Description

Tirzepatide Sodium Overview

Tirzepatide Sodium is a synthetic peptide developed for laboratory research into dual receptor pathways involving glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). With its distinct sequence and structure, Tirzepatide is of high interest in metabolic and biochemical studies focused on receptor interactions and regulation of glucose and lipid metabolism.

Product Details

• Amino Acid Sequence: YE-Aib-GTFSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS

• Note: Aib is a non-coded (non-proteinogenic) amino acid – H₂H-C(CH₃)₂-COOH

• Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈

• Molecular Weight: 4813.527 g/mol

• PubChem CID: 156588324

• CAS Number: 2023788-19-2

Research Highlights

• Incretin Pathway Studies: Investigated for its dual agonist action on GIP and GLP-1 receptors, offering insights into glucose and lipid regulation in research models.

• Receptor Binding Analysis: Its structure makes it a strong candidate for examining receptor binding and pathway activation in laboratory-based systems.

Usage and Safety Information

This product is intended for laboratory research only. It is not approved for human or veterinary use. Laboratory safety standards must be followed when handling Tirzepatide Sodium.

Disclaimer

All information provided is for scientific and educational purposes. This compound is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.

Important Notices

• Supplied strictly for scientific research purposes.

• Provided as a lyophilized (freeze-dried) powder in a sterile, sealed vial.

• Label quantity refers to the total content of each vial.

• Requires additional laboratory materials for research, including bacteriostatic water (for reconstitution), syringes, needles, and alcohol pads for vial sanitization.

• Vial appearance, labeling, cap, and seal colors may differ from product images.